Skip to content

Monovision for the Treatment of Diplopia

Monovision for Treatment of Diplopia

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01426672
Enrollment
20
Registered
2011-08-31
Start date
2009-01-31
Completion date
2011-01-31
Last updated
2011-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Strabismic Deviation

Keywords

Strabismic deviation less than 12 prism diopeters

Brief summary

PURPOSE: The purpose of this study is to quantitatively assess the efficacy of monovision correction in the treatment of acquired small angle binocular diplopia in adult patients. METHOD: Twenty patients with symptomatic diplopia were enrolled in a prospective treatment trial. All had stable deviations of 10 prism diopters or less for over three months. Each received monovision spectacles and/ or contact lenses with distance correction in the dominant eye. Half received a +3.00 diopter (D) add and the others received +2.50 D. The validated and standardized Diplopia Questionnaire and Amblyopia and Strabismus Questionnaire (ASQE) were used to quantify the efficacy of monovision correction for diplopia by measuring the functional impact on vision-specific quality of life.

Interventions

OTHERMonovision Correction (with the help of glasses or contact lenses)

Sponsors

Mount Sinai Hospital, Canada
Lead SponsorOTHER

Study design

Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Strabismic Deviation less than 12 Prism Diopters

Exclusion criteria

* Inability to sign informed consent

Design outcomes

Primary

MeasureTime frameDescription
Patients satisfaction with monovision was measured by standardized diplopia questionnaire and results reported in statistical terms on multiple measures tested on the questionnaire.2 yearsTo determine whether monovision correction was useful for the correction of small angle deviations in strabismic patients

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026